The ceasefire that was supposed to quiet the Middle East lasted exactly two weeks. After a marathon 21-hour negotiating session in Islamabad collapsed over the weekend, the U.S. announced it would begin a naval blockade of Iranian ports starting Monday morning, cutting off Iran’s oil shipments through the Strait of Hormuz. For investors holding SPDR S&P Aerospace & Defense ETF (NYSEARCA:XAR | XAR Price Prediction), this is the environment the fund was built for.
The Conflict That Rewrote Defense Budgets
The 2026 Iran war began on February 28, when the U.S. and Israel launched coordinated strikes targeting Iran’s nuclear and ballistic missile programs. Iran responded with missile and drone attacks against U.S. bases and Israeli territory. A two-week ceasefire brokered by Pakistan took effect on April 8, but talks in Islamabad broke down over the weekend, with both sides blaming the other. Now the U.S. Navy is enforcing a blockade across Iranian Gulf ports, oil briefly crossed $100 a barrel, and the fragile ceasefire is hanging by a thread.
Defense budgets are moving in one direction. Trump’s fiscal 2027 budget requests $1.5 trillion in defense spending, a roughly 40% year-over-year increase, covering major planned boosts in aircraft, munitions, and missile defense. This structural tailwind flows directly through XAR’s holdings.
What XAR Owns and How It Makes Money
XAR tracks the S&P Aerospace and Defense Select Industry Index using an equal-weight methodology. Every position gets roughly the same allocation, around 3%, regardless of market cap. That means smaller innovators sit alongside big defense contractors with the same weight.
The return engine is straightforward: earnings growth and cash flow expansion across the entire defense supply chain. The fund carries no leverage, charges a 0.35% net expense ratio, and holds 41 positions concentrated in defense stocks. Income is minimal at a 0.14% dividend yield, so investors here are buying for price appreciation, not payouts.
Portfolio turnover sits at 0.35, which is notably low, meaning holdings are not actively rotated in response to news cycles. Investors get stable, long-term exposure to the defense supply chain rather than tactical repositioning.
A Year That Proved the Thesis
XAR has delivered. Over the past year, the fund returned nearly 66%, rising from around $159 to over $270. Year-to-date in 2026, XAR is up 8%. Over ten years, the fund has gained 18.8% annually.
Major holdings are echoing that strength. Lockheed Martin (NYSE:LMT) is up about 25% year-to-date, and Northrop Grumman (NYSE:NOC) has gained roughly 16% in the same period. Both names sit near equal weight inside XAR, meaning the fund captures their gains without overconcentrating in any single prime contractor.
The Tradeoffs Are Real
Three constraints matter here:
- Single-sector concentration with no cushion. XAR allocates nearly all assets to industrials, with no exposure to technology, healthcare, or any other sector. If defense budgets contract or procurement cycles slow, there is nothing else in the fund to absorb the hit. This is a conviction bet, not a diversified position.
- Equal weighting amplifies volatility. Giving smaller innovators the same weight as large prime contractors means the fund moves sharply during risk-off periods. Smaller names sell off harder and faster than the primes. Investors accept that volatility in exchange for upside when defense innovators outperform established contractors.
- Geopolitical risk cuts both ways. A genuine peace deal with Iran, a ceasefire that holds, or a congressional reversal of defense spending priorities could compress the fund quickly. The low portfolio turnover means the fund will not reposition ahead of those shifts.
XAR makes the most sense as a targeted sector sleeve for investors who believe elevated defense spending persists beyond the current conflict, with the understanding that a durable peace settlement would likely trigger a sharp reversal in the fund’s recent run.
Top Gaining Stocks
Top Losing Stocks